Tata Memorial To Build India’s Largest Bone Marrow Centre
ECONOMY & POLICY

Tata Memorial To Build India’s Largest Bone Marrow Centre

The Tata Memorial Centre’s Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Kharghar will soon house India’s largest bone marrow transplant (BMT) facility, with funding support of Rs 3.8 billion from the National Stock Exchange (NSE) through its Corporate Social Responsibility (CSR) initiative.

The 11-storey facility, to be named the NSE Multispecialty Hospital Block and Bone Marrow Transplant Cancer Hospital, will be built by Larsen & Toubro (L&T). A bhoomipujan ceremony was held on Sunday to mark the project’s commencement. Once construction is completed, the building will be handed over to ACTREC.

Dr Pankaj Chaturvedi, Director of ACTREC, said the new 60-bed facility would significantly expand the centre’s capabilities. “At present, we have a five-bed BMT centre. Once the new building is ready, we will be able to perform 600 bone marrow transplants each year,” he said.

Expected to be operational by July 2027, the centre will also handle about 130,000 outpatient consultations annually, vastly improving access to specialised cancer care.

ACTREC currently performs over 100 bone marrow transplants every year and treats more than 300 patients daily. It also pioneered India’s first indigenous CAR-T cell therapy for blood cancer in 2021.

Dr Chaturvedi added that the upcoming facility would offer the most affordable bone marrow transplants in the country. While the procedure can cost over Rs 40 lakh (Rs 4 million) in private hospitals and upwards of Rs 10 lakh (Rs 1 million) even in public institutions, the Tata Memorial Centre helps families secure financial assistance through donations and charity support.

The groundbreaking ceremony was attended by key dignitaries, including Ashishkumar Chauhan, Managing Director and Chief Executive Officer of NSE; Dr Sudeep Gupta, Director, Tata Memorial Centre; Dr Pankaj Chaturvedi, Director, ACTREC; and Dr Navin Khattry, Deputy Director, ACTREC and Head of the BMT Programme.

According to an NSE release, “This collaboration represents a major step toward bridging the gap in affordable, high-quality cancer care across India, bringing critical treatment access to thousands in need.”



The Tata Memorial Centre’s Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) in Kharghar will soon house India’s largest bone marrow transplant (BMT) facility, with funding support of Rs 3.8 billion from the National Stock Exchange (NSE) through its Corporate Social Responsibility (CSR) initiative.The 11-storey facility, to be named the NSE Multispecialty Hospital Block and Bone Marrow Transplant Cancer Hospital, will be built by Larsen & Toubro (L&T). A bhoomipujan ceremony was held on Sunday to mark the project’s commencement. Once construction is completed, the building will be handed over to ACTREC.Dr Pankaj Chaturvedi, Director of ACTREC, said the new 60-bed facility would significantly expand the centre’s capabilities. “At present, we have a five-bed BMT centre. Once the new building is ready, we will be able to perform 600 bone marrow transplants each year,” he said.Expected to be operational by July 2027, the centre will also handle about 130,000 outpatient consultations annually, vastly improving access to specialised cancer care.ACTREC currently performs over 100 bone marrow transplants every year and treats more than 300 patients daily. It also pioneered India’s first indigenous CAR-T cell therapy for blood cancer in 2021.Dr Chaturvedi added that the upcoming facility would offer the most affordable bone marrow transplants in the country. While the procedure can cost over Rs 40 lakh (Rs 4 million) in private hospitals and upwards of Rs 10 lakh (Rs 1 million) even in public institutions, the Tata Memorial Centre helps families secure financial assistance through donations and charity support.The groundbreaking ceremony was attended by key dignitaries, including Ashishkumar Chauhan, Managing Director and Chief Executive Officer of NSE; Dr Sudeep Gupta, Director, Tata Memorial Centre; Dr Pankaj Chaturvedi, Director, ACTREC; and Dr Navin Khattry, Deputy Director, ACTREC and Head of the BMT Programme.According to an NSE release, “This collaboration represents a major step toward bridging the gap in affordable, high-quality cancer care across India, bringing critical treatment access to thousands in need.” 

Next Story
Infrastructure Urban

VECV Sales Rise 7.8 Per Cent In May 2026

VE Commercial Vehicles recorded sales of 7,978 units in May 2026, compared to 7,401 units in May 2025, registering growth of 7.8 per cent. This included 7,789 units from the Eicher brand and 189 units from the Volvo brand.Eicher branded trucks and buses reported sales of 7,789 units during the month, up 7.3 per cent from 7,258 units a year earlier. In the domestic commercial vehicle market, Eicher sales rose 9.1 per cent to 7,375 units from 6,758 units in May 2025.Exports declined 17.2 per cent to 414 units from 500 units in the corresponding month last year. Volvo Trucks and Volvo Buses recor..

Next Story
Infrastructure Urban

Table Space Strengthens DESYN Leadership Team

Table Space has announced strategic leadership appointments within DESYN, its integrated Design and Build business, as it looks to strengthen operations across key enterprise and GCC markets in India. DESYN was launched as a strategic extension of Table Space’s workspace solutions portfolio to meet rising demand for agile, high-quality and rapidly deployable enterprise workspaces.Shruti Ookabhoy has joined DESYN as Executive Director and will lead the Design vertical, focusing on design capability, operational excellence and team development across markets. She brings over 22 years of experi..

Next Story
Infrastructure Transport

Concord Associate Bags Rs 2.79 Bn Kavach Order

Concord Control Systems said its associate company, Progota India, has received a Rs 2.79 bn domestic order from Indian Railways for the supply, installation, testing and commissioning of on-board Kavach 4.0 loco equipment.The order is scheduled for execution within 12 months and strengthens Concord’s role in India’s railway safety and signalling ecosystem. Kavach is India’s indigenous automatic train protection system, designed to improve operational safety by helping prevent signal passing at danger and reducing collision risks.Gaurav Lath, Joint Managing Director, Concord Control Syst..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement